116 related articles for article (PubMed ID: 26291835)
81. Chemical synthesis, characterisation and biological evaluation of lactonic-estradiol derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1.
Farhane S; Fournier MA; Poirier D
J Steroid Biochem Mol Biol; 2013 Sep; 137():322-31. PubMed ID: 23685015
[TBL] [Abstract][Full Text] [Related]
82. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate.
Lin HK; Steckelbroeck S; Fung KM; Jones AN; Penning TM
Steroids; 2004 Dec; 69(13-14):795-801. PubMed ID: 15582534
[TBL] [Abstract][Full Text] [Related]
83. Estrone C15 derivatives--a new class of 17beta-hydroxysteroid dehydrogenase type 1 inhibitors.
Messinger J; Husen B; Koskimies P; Hirvelä L; Kallio L; Saarenketo P; Thole H
Mol Cell Endocrinol; 2009 Mar; 301(1-2):216-24. PubMed ID: 19014997
[TBL] [Abstract][Full Text] [Related]
84. Ex vivo and in vitro testis and ovary explants: utility for identifying steroid biosynthesis inhibitors and comparison to a Tier I screening battery.
Powlin SS; Cook JC; Novak S; O'Connor JC
Toxicol Sci; 1998 Nov; 46(1):61-74. PubMed ID: 9928669
[TBL] [Abstract][Full Text] [Related]
85. Rational design of 17β-hydroxysteroid dehydrogenase type3 for improving testosterone production with an engineered Pichia pastoris.
Ding J; You S; Zhang J; Zhang H; Wang H; Zhang W; Qi W; Su R; He Z
Bioresour Technol; 2021 Dec; 341():125833. PubMed ID: 34455250
[TBL] [Abstract][Full Text] [Related]
86. Lessons from 17β-HSD3 deficiency: Clinical spectrum and complex molecular basis in Chinese patients.
Zhu H; Yao H; Liu X; Xu Y; Liu Y; Luo Q; Chen Y; Shi Y; Chen F; Zhao S; Song H; Han B; Qiao J
J Steroid Biochem Mol Biol; 2023 Jan; 225():106191. PubMed ID: 36154887
[TBL] [Abstract][Full Text] [Related]
87. Synthesis of 5α-androstane-17-spiro-δ-lactones with a 3-keto, 3-hydroxy, 3-spirocarbamate or 3-spiromorpholinone as inhibitors of 17β-hydroxysteroid dehydrogenases.
Djigoué GB; Ngatcha BT; Roy J; Poirier D
Molecules; 2013 Jan; 18(1):914-33. PubMed ID: 23344201
[TBL] [Abstract][Full Text] [Related]
88. Increased 3β-hydroxysteroid dehydrogenase 2 and 17α-hydroxylase activities in a virilized adolescent female with adrenal adenoma: A case report.
Yang G; Dou J; Zhang X; Gu W; Lv Z; DU J; Ba J; Mu Y; Lu J
Exp Ther Med; 2016 Feb; 11(2):530-534. PubMed ID: 26893641
[TBL] [Abstract][Full Text] [Related]
89. 17beta-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite.
Mains LM; Vakili B; Lacassie Y; Andersson S; Lindqvist A; Rock JA
Fertil Steril; 2008 Jan; 89(1):228.e13-7. PubMed ID: 17509588
[TBL] [Abstract][Full Text] [Related]
90. Four novel mutations identification in 17 beta-hydroxysteroid dehydrogenase-3 deficiency and our clinical experience: possible benefits of early treatment.
Wang Y; Xu Y; Zhang H; Yin D; Pan Y; He X; Li S; Cheng Z; Zhu G; Zhao T; Huang H; Zhu M
Front Endocrinol (Lausanne); 2023; 14():1267967. PubMed ID: 38425490
[TBL] [Abstract][Full Text] [Related]
91. Down-regulation of murine testicular 17β-HSD3 and hepatic CYP1A2 enzymes by a bovine testes extract.
Chatuphonprasert W; Thadsri T; Jarukamjorn K
Reprod Med Biol; 2010 Mar; 9(1):51-56. PubMed ID: 29699329
[TBL] [Abstract][Full Text] [Related]
92. Physiologically relevant fluorescent assay for identification of 17β-hydroxysteroid dehydrogenase type 10 inhibitors.
Schmidt M; Vaskova M; Rotterova A; Fiandova P; Miskerikova M; Zemanova L; Benek O; Musilek K
J Neurochem; 2023 Oct; 167(2):154-167. PubMed ID: 37458164
[TBL] [Abstract][Full Text] [Related]
93. Analyses of Molecular Characteristics and Enzymatic Activities of Ovine HSD17B3.
Islam MS; Uwada J; Hayashi J; Kikuya KI; Muranishi Y; Watanabe H; Yaegashi K; Hasegawa K; Ida T; Sato T; Imamichi Y; Kitano T; Miyashiro Y; Khan RI; Takahashi S; Umezawa A; Suzuki N; Sekiguchi T; Yazawa T
Animals (Basel); 2021 Sep; 11(10):. PubMed ID: 34679897
[TBL] [Abstract][Full Text] [Related]
94. In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3.
Roy J; Fournier MA; Maltais R; Kenmogne LC; Poirier D
J Steroid Biochem Mol Biol; 2014 May; 141():44-51. PubMed ID: 24434282
[TBL] [Abstract][Full Text] [Related]
95. Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models.
Kenmogne LC; Roy J; Maltais R; Rouleau M; Neveu B; Pouliot F; Poirier D
PLoS One; 2017; 12(2):e0171871. PubMed ID: 28182747
[TBL] [Abstract][Full Text] [Related]
96. Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.
Djigoué GB; Kenmogne LC; Roy J; Maltais R; Poirier D
Bioorg Med Chem; 2015 Sep; 23(17):5433-51. PubMed ID: 26277760
[TBL] [Abstract][Full Text] [Related]
97. Development of 17β-hydroxysteroid dehydrogenase type 3 as a target in hormone-dependent prostate cancer therapy.
Ning X; Yang Y; Deng H; Zhang Q; Huang Y; Su Z; Fu Y; Xiang Q; Zhang S
Steroids; 2017 May; 121():10-16. PubMed ID: 28267564
[TBL] [Abstract][Full Text] [Related]
98. Pathways and genes involved in steroid hormone metabolism in male pigs: a review and update.
Robic A; Faraut T; Prunier A
J Steroid Biochem Mol Biol; 2014 Mar; 140():44-55. PubMed ID: 24239507
[TBL] [Abstract][Full Text] [Related]
99. Reprint of "In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3".
Roy J; Fournier MA; Maltais R; Kenmogne LC; Poirier D
J Steroid Biochem Mol Biol; 2015 Sep; 153():170-8. PubMed ID: 26291835
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
